China's Nasal Spray Coronavirus Vaccine Starts Phase 1 Study

China's only nasal spray vaccine against the novel coronavirus is expected to start phase I clinical trials in November 2020, reported Global Times on September 10, 2020. The nasal spray vaccine uses a live attenuated influenza vaccine. This nasal spray vaccine candidate is a collaborative effort between the University of Hong Kong, Xiamen University, and Beijing Wantai Biological Pharmacy.

This coronavirus nasal spray vaccine candidate has been approved by China's National Medical Products Administration. China has approved 10 coronavirus vaccines for clinical trials, including inactivated vaccines, adenoviral vector-based vaccines, and DNA and mRNA vaccines.